Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Malignant Melanoma

  Free Subscription


11.09.2017

1 Ann Surg
1 Anticancer Res
1 Br J Cancer
1 Br J Dermatol
1 Cancer Res
1 J Am Acad Dermatol
1 J Invest Dermatol
3 Lancet Oncol
4 Melanoma Res
1 Oncogene
1 PLoS Comput Biol
2 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Surg


  1. Diagnosis and Treatment of Intestinal Melanoma Metastases in the Era of Effective Systemic Treatment: Retraction.
    Ann Surg. 2017 Sep 6. doi: 10.1097/SLA.0000000000002481.
    PubMed     Text format    


    Anticancer Res

  2. USLU U, Schliep S, Schliep K, Erdmann M, et al
    Comparison of the Serum Tumor Markers S100 and Melanoma-inhibitory Activity (MIA) in the Monitoring of Patients with Metastatic Melanoma Receiving Vaccination Immunotherapy with Dendritic Cells.
    Anticancer Res. 2017;37:5033-5037.
    PubMed     Text format     Abstract available


    Br J Cancer

  3. KUZU OF, Gowda R, Noory MA, Robertson GP, et al
    Modulating cancer cell survival by targeting intracellular cholesterol transport.
    Br J Cancer. 2017;117:513-524.
    PubMed     Text format     Abstract available


    Br J Dermatol

  4. SATTLER EC, Ertl-Wagner B, Pellegrini C, Peris K, et al
    Cutaneous melanoma in Birt-Hogg-Dube syndrome - part of the clinical spectrum?
    Br J Dermatol. 2017 Sep 4. doi: 10.1111/bjd.15937.
    PubMed     Text format     Abstract available


    Cancer Res

  5. KIRTANE AR, Sadhukha T, Kim H, Khanna V, et al
    Fibrinolytic Enzyme Cotherapy Improves Tumor Perfusion and Therapeutic Efficacy of Anticancer Nanomedicine.
    Cancer Res. 2017;77:1465-1475.
    PubMed     Text format     Abstract available


    J Am Acad Dermatol

  6. PAMPENA R, Kyrgidis A, Lallas A, Moscarella E, et al
    A meta-analysis of nevus-associated melanoma: Prevalence and practical implications.
    J Am Acad Dermatol. 2017 Aug 22. pii: S0190-9622(17)32051.
    PubMed     Text format     Abstract available


    J Invest Dermatol

  7. HAUGH AM, Zhang B, Quan VL, Garfield EM, et al
    Distinct Patterns of Acral Melanoma Based on Site and Relative Sun Exposure.
    J Invest Dermatol. 2017 Sep 1. pii: S0022-202X(17)32917.
    PubMed     Text format     Abstract available


    Lancet Oncol

  8. DAVIES MA, Saiag P, Long GV
    Primary medical therapy for BRAFV600E-mutant melanoma brain metastases-is this good enough? - Authors' reply.
    Lancet Oncol. 2017;18:e509.
    PubMed     Text format    

  9. BAKER H
    Discontinuation of melanoma combination immunotherapy.
    Lancet Oncol. 2017 Sep 1. pii: S1470-2045(17)30668.
    PubMed     Text format    

  10. KRUSER TJ, Vogelbaum MA
    Primary medical therapy for BRAFV600E-mutant melanoma brain metastases-is this good enough?
    Lancet Oncol. 2017;18:e508.
    PubMed     Text format    


    Melanoma Res

  11. TAHA T, Tzuk-Shina T, Forschner I, Bar-Sela G, et al
    Acute motor and sensory axonal neuropathy related to treatment with MEK inhibitors in a patient with advanced melanoma.
    Melanoma Res. 2017 Sep 1. doi: 10.1097/CMR.0000000000000390.
    PubMed     Text format     Abstract available

  12. YUKI A, Takenouchi T, Takatsuka S, Ishiguro T, et al
    A case of pure red cell aplasia during nivolumab therapy for cardiac metastatic melanoma.
    Melanoma Res. 2017 Sep 1. doi: 10.1097/CMR.0000000000000392.
    PubMed     Text format     Abstract available

  13. DE SOUZA NETO FP, Bernardes SS, Marinello PC, Melo GP, et al
    Metformin: oxidative and proliferative parameters in-vitro and in-vivo models of murine melanoma.
    Melanoma Res. 2017 Sep 4. doi: 10.1097/CMR.0000000000000391.
    PubMed     Text format     Abstract available

  14. MARTINEZ-GARCIA MA, Riveiro-Falkenbach E, Rodriguez-Peralto JL, Nagore E, et al
    A prospective multicenter cohort study of cutaneous melanoma: clinical staging and potential associations with HIF-1alpha and VEGF expressions.
    Melanoma Res. 2017 Sep 6. doi: 10.1097/CMR.0000000000000393.
    PubMed     Text format     Abstract available


    Oncogene

  15. DOUDICAN NA, Orlow SJ
    Inhibition of the CRAF/prohibitin interaction reverses CRAF-dependent resistance to vemurafenib.
    Oncogene. 2017;36:423-428.
    PubMed     Text format     Abstract available


    PLoS Comput Biol

  16. AURICH MK, Fleming RMT, Thiele I
    A systems approach reveals distinct metabolic strategies among the NCI-60 cancer cell lines.
    PLoS Comput Biol. 2017;13:e1005698.
    PubMed     Text format     Abstract available


    PLoS One

  17. NOBEYAMA Y, Nakagawa H
    Silencing of interferon regulatory factor gene 6 in melanoma.
    PLoS One. 2017;12:e0184444.
    PubMed     Text format     Abstract available

  18. MASUDA Y, Nakayama Y, Tanaka A, Naito K, et al
    Antitumor activity of orally administered maitake alpha-glucan by stimulating antitumor immune response in murine tumor.
    PLoS One. 2017;12:e0173621.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  19. INGRAM JR, Blomberg OS, Sockolosky JT, Ali L, et al
    Localized CD47 blockade enhances immunotherapy for murine melanoma.
    Proc Natl Acad Sci U S A. 2017 Sep 5. pii: 201710776.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: